Van Diest Capital’s Colgate-Palmolive CL Stock Holding History

Van Diest Capital’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2,713	Closed	-$214K	–	191
2025 Q4	$214K	Buy	+2,713	New	+$213K	0.32%	123

Other funds holding CL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Van Diest Capital's CL Position: Q1 2026 in Review

Van Diest Capital sold out of Colgate-Palmolive (CL) in Q1 2026, closing a stake of 2,713 shares — an estimated $214K sold.

Van Diest Capital first reported a position in CL in Q4 2025 and held it in 1 quarter. The position peaked at $214K in Q4 2025. 1,966 funds tracked by Wall St. Rank hold CL as of Q1 2026.

Van Diest Capital reported no remaining Colgate-Palmolive position as of Q1 2026 after selling out during the quarter.
Van Diest Capital sold 2,713 Colgate-Palmolive shares in Q1 2026, an estimated $214K.
Van Diest Capital first reported a position in Colgate-Palmolive in Q4 2025 and held it in 1 quarter.
Van Diest Capital's Colgate-Palmolive position peaked at $214K in Q4 2025.
1,966 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Van Diest Capital's 13F filing for Q1 2026, filed 15 May 2026.